Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone maintenance therapy in pemphigus vulgaris
IRCT20190813044524N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of prednisolone in pemphigus vulgaris (PV) (4 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Recurrence rate, Incidence of diabetes and 4 more. Started Apr 2020; status: completed.
02
Drugs
prednisolone
03
Conditions
pemphigus vulgaris (PV)
Beyond the preview
Go deeper on IRCT20190813044524N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190813044524N1.